Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03382652 · ClinicalTrials.gov registry record

Continuum™ Metal Bearing System in Total Hip Arthroplasty

A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by Zimmer Biomet.

Completed
Registry status
83
Enrollment target
3
Study locations

NCT03382652 is a study of Osteoarthritis and Avascular Necrosis that has completed, run by Zimmer Biomet. The registered enrollment target is 83 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03382652, a study of Osteoarthritis and Avascular Necrosis, has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
83 participants
Enrollment target
3
Study locations

Study Summary

The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and outcome data on the Continuum Metal Bearing System in primary total hip arthroplasty.

Interventions

  • DEVICE Metal-on-Metal Articulation

Study Locations (3)

Other

  • Jokilaakson terveys oy - Jämsä
  • Hospital District of Southwest Finland - Turku

Texas

  • Saint Davids Medical Center - Austin

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2011-02-09
Est. Completion 2022-10-22

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT03382652

The ClinicalTrials.gov registry entry for NCT03382652 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Metal-on-Metal Articulation is the first listed.

NCT03382652 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, Texas.

Frequently Asked Questions

What is clinical trial NCT03382652 about?

NCT03382652 is a clinical study titled "Continuum™ Metal Bearing System in Total Hip Arthroplasty". The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and outcome data on the Continuum Metal Bearing System in primary total hip arthroplasty.

What is the current status of trial NCT03382652?

This trial is currently completed. The enrollment target is 83 participants. The study started on 2011-02-09. Estimated completion is 2022-10-22.

What conditions does trial NCT03382652 study?

This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis, Total Hip Arthroplasty, Inflammatory Arthritis, Post-traumatic; Arthrosis.

What interventions are being tested in trial NCT03382652?

The interventions under investigation include: Metal-on-Metal Articulation (DEVICE).

Who is sponsoring clinical trial NCT03382652?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03382652 being conducted?

This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.